Anti-RhD antibody therapy modulates human natural killer cell function

Anti-RhD antibodies are widely used in clinical practice to prevent immunization against RhD, principally in hemolytic disease of the fetus and newborn. Intriguingly, this disease is induced by production of the very same antibodies when an RhD negative woman is pregnant with an RhD positive fetus....

Descripción completa

Detalles Bibliográficos
Autores principales: Elias, Shlomo, Kol, Inbal, Kahlon, Shira, Amore, Rajaa, Zeibak, Mariam, Mevorach, Dror, Elchalal, Uriel, Zelig, Orly, Mandelboim, Ofer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252960/
https://www.ncbi.nlm.nih.gov/pubmed/32467141
http://dx.doi.org/10.3324/haematol.2019.238097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252960/
https://www.ncbi.nlm.nih.gov/pubmed/32467141
http://dx.doi.org/10.3324/haematol.2019.238097

Ejemplares similares